SynopsisIt is antitumor drug, is the precursor of fluorouracil (5 FU), within the tumor tissue by the effect of pyrimidine nucleoside phosphorylase, converted to free fluorouracil, thereby inhibiting tumor cell biosynthesis of DNA, RNA, shows that its anti-tumor effec.....
SynopsisTegafur is effective for gastric, colon, rectal, pancreatic and other digestive cancers, as well as for breast and liver cancers. The global Tegafur (Futraful) market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witn.....
SynopsisCommonly used dosage forms are tablets, oral liquid, injection, the main medicinal components for the wuguteng, with anti-inflammatory, antiasthmatic, anti-cancer effect. The global Chlorogenic market was valued at US$ million in 2023 and is anticipated .....
SynopsisBrucea Javanica Oil is a cancer drug.For lung cancer, brain metastasis of lung cancer and gastrointestinal tumors. The global Brucea Javanica Oil market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR .....
SynopsisCalcium levovate, indicated in combination with 5-fluorouracil for the treatment of gastric and colorectal cancer. The global Calcium Levofolinate market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR.....
SynopsisItraconazole (Sporanox), a new generation of triazole, is a highly effective broad-spectrum antifungal drug that can inhibit the synthesis of ergosterol by combining with fungal cytochrome P450 isoenzyme.This product is effective for tinea dermatia, candida, c.....
SynopsisVoriconazole is a broad-spectrum antifungal agent for fungal infections in humans and animals. The global Voriconazole Vfend market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forec.....
SynopsisClaricid (CLARY）is also known as Clarithromycin and it is a derivative of erythromycin. The global Claricid (CLARY） market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast perio.....
SynopsisLinezolid is a synthetic antibiotic, the first of the oxazolidinone class, used for the treatment of infections caused by multi-resistant bacteria including streptococcus and methicillin-resistant Staphylococcus aureus (MRSA). The drug works by inhibiting the .....
SynopsisCefuroxim The global Cefuroxim market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. North American market for Cefuroxim is estimated to increase from .....
